First Trust Advisors’s Adaptive Biotechnologies ADPT Stock Holding History

First Trust Advisors’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.96M	Sell	417,823 -136,761	-25%	-$2.1M	0.01%	1257
2026 Q1	$7.7M	Buy	554,584 +15,508	+3%	+$247K	0.01%	1226
2025 Q4	$8.75M	Sell	539,076 -4,061	-0.7%	-$66.3K	0.01%	1158
2025 Q3	$8.13M	Sell	543,137 -198,169	-27%	-$2.41M	0.01%	1162
2025 Q2	$8.64M	Buy	741,306 +726,184	+4,802%	+$6.6M	0.01%	1136
2025 Q1	$112K	Sell	15,122 -1,335	-8%	-$10.3K	﹤0.01%	2504
2024 Q4	$98.7K	Buy	+16,457	New	+$90.7K	﹤0.01%	2528
2023 Q3	–	Sell	-125,630	Closed	-$843K	–	2344
2023 Q2	$843K	Buy	+125,630	New	+$934K	﹤0.01%	2028
2021 Q2	–	Sell	-326,635	Closed	-$13.2M	–	2470
2021 Q1	$13.2M	Sell	326,635 -144,731	-31%	-$7.83M	0.02%	852
2020 Q4	$27.9M	Sell	471,366 -78,356	-14%	-$4.04M	0.04%	534
2020 Q3	$26.7M	Buy	549,722 +493,526	+878%	+$20.7M	0.04%	463
2020 Q2	$2.72M	Buy	+56,196	New	+$2.05M	﹤0.01%	1227

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

First Trust Advisors's ADPT Position: Q2 2026 in Review

First Trust Advisors reduced its Adaptive Biotechnologies (ADPT) stake by 25% in Q2 2026, selling an estimated $2.1M and leaving 417,823 shares worth $8.96M. The position accounts for 0.01% of the portfolio, ranked #1257.

First Trust Advisors first reported a position in ADPT in Q2 2020 and has held it in 12 quarters since. The position peaked at $27.9M in Q4 2020. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

First Trust Advisors held 417,823 shares of Adaptive Biotechnologies worth $8.96M as of Q2 2026.
First Trust Advisors sold 136,761 Adaptive Biotechnologies shares in Q2 2026, an estimated $2.1M.
Adaptive Biotechnologies made up 0.01% of First Trust Advisors's portfolio in Q2 2026, its #1257 holding.
First Trust Advisors first reported a position in Adaptive Biotechnologies in Q2 2020 and has held it in 12 quarters since.
First Trust Advisors's Adaptive Biotechnologies position peaked at $27.9M in Q4 2020.
301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.